Related Experiment Videos
The regulatory subunit of protein kinase CK2 is a specific A-Raf activator
C Hagemann1, A Kalmes, V Wixler
1Institut für med. Strahlenkunde und Zellforschung, Bayerische Julius-Maximillians-Universität, Würzburg, Germany.
Abstract:
Two protein kinases that are involved in proliferation and oncogenesis but so far were thought to be functionally independent are Raf and CK2. The Raf signaling pathway is known to play a critical role in such fundamental biological processes as cellular proliferation and differentiation. Abnormal activation of this pathway is potentially oncogenic. Protein kinase CK2 exhibits enhanced levels in solid human tumors and proliferating tissue. In a two-hybrid screen of a mouse-embryo cDNA library we detected an interaction between A-Raf and CK2beta subunit. This binding was specific, as no interaction between CK2beta and B-Raf or c-Raf-1 was observed. Regions critical for this interaction were localized between residues 550 and 569 in the A-Raf kinase domain. A-Raf kinase activity was enhanced 10-fold upon coexpression with CK2beta in Sf9 cells. The alpha subunit of CK2 abolishes this effect. This is the first demonstration of both a direct Raf-isoform-specific activation and a regulatory role for CK2beta independent of the CK2alpha subunit. The present data thus link two different protein kinases that were thought to work separately in the cell.
Insights
This study reveals a direct interaction between A-Raf and CK2beta, a subunit of protein kinase CK2. This interaction specifically enhances A-Raf kinase activity, linking two previously independent signaling pathways involved in cell proliferation and cancer.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncogenesis
Background:
- Raf and CK2 are protein kinases involved in cell proliferation and oncogenesis.
- These kinases were previously considered functionally independent.
- CK2 is often upregulated in human tumors and proliferating tissues.
Purpose of the Study:
- To investigate potential interactions between Raf kinases and CK2.
- To elucidate the functional consequences of any observed interactions.
Main Methods:
- Yeast two-hybrid screening using a mouse-embryo cDNA library.
- Coexpression of proteins in Sf9 cells to assess kinase activity.
- Site-directed mutagenesis to map interaction domains.
Main Results:
- A specific interaction was detected between A-Raf and the CK2beta subunit, but not B-Raf or c-Raf-1.
- The interaction site was mapped to residues 550-569 within the A-Raf kinase domain.
- Coexpression with CK2beta significantly enhanced A-Raf kinase activity (10-fold), an effect abolished by the CK2alpha subunit.
Conclusions:
- This study demonstrates a direct, isoform-specific activation of A-Raf by CK2beta, independent of CK2alpha.
- It links the Raf and CK2 signaling pathways, suggesting a novel regulatory mechanism in cell proliferation and oncogenesis.